01/07/2024
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Aug »
01/07/2024
Jul 1, 2024, 23:51 |
Insight
Piotr Wysocki: Neoadjuvant therapy for renal-cell cancer patients is still in its infancy, unlike in melanoma
Piotr Wysocki recently posted on LinkedIn: "The PROSPER ECOG-ACRIN EA8143 study (published online in Lancet…
Jul 1, 2024, 19:36 |
Blog
Monica Bertagnolli: Molecular Portrait of Key Driver of pancreatic cancer
Monica Bertagnolli shared on LinkedIn: “A pancreatic cancer diagnosis is frightening. NIH-funded research may offer…
Jul 1, 2024, 19:24 |
Insight
Léa Ikhlef: The use of extracellular vesicles as a communication tool by TAMS in CLL
Léa Ikhlef, Postdoctoral researcher at Léon Bérard Center, shared on LinkedIn: “I'm glad to share…
Jul 1, 2024, 19:16 |
Insight
Susanna Greer: This researcher is making tools to improve quality of life
Susanna Greer, Chief Scientific Officer at The V Foundation for Cancer Research, shared on LinkedIn:…
Jul 1, 2024, 19:04 |
Blog
Julie S. Torode: Ethiopia‘s first ever breast cancer guideline
Julie S. Torode, Board Member and Director of Strategic Partnerships of Institute of Cancer Policy,…
Jul 1, 2024, 18:48 |
Blog
Yüksel Ürün: Empowering Cancer Survivors with Employment Support!
Yüksel Ürün shared a post on X: “Empowering Cancer Survivors with Employment Support! Many cancer…
Jul 1, 2024, 18:24 |
Insight
Paolo Tarantino: How long should adjuvant T-DM1 be given for stage I HER2+ eBC?
Paolo Tarantino shared on X: "For how long should adjuvant T-DM1 be given for stage…
Jul 1, 2024, 18:12 |
Blog
Two great minds teaming up to fight cancer - Saint John’s Cancer Institute
Saint John’s Cancer Institute posted on LinkedIn: “A Shared Vision: Two great minds, two great…
Jul 1, 2024, 18:02 |
Blog
Kai-Cheng Hsu: 25 Years of Innovation and Excellence in Biomedical Technology!
Kai-Cheng Hsu shared a post on LinkedIn: “Celebrating 25 Years of Innovation and Excellence in…
Jul 1, 2024, 17:38 |
Blog
Sara Elena Rebuzzi: Study protocol of the ongoing study on the first-line therapy in mRCC patients
Sara Elena Rebuzzi, Medical Oncologis at The Hospital of San Paolo, made the following post…
1
2
3
4
5
All:
99
Posts:
1 - 10
43 Posts Not To Miss From ESMO24 Day 2
45 Posts not to miss from ESMO24 Day 1
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube